Recursionauts Series: Joseph Miletich, MD, PhD

Meet Dr. Joseph Miletich, M.D., Ph.D. - SVP of Research at Merck and Chair of Recursion’s Therapeutic Advisory Board.
In the latest episode of our Recursionauts series, Dr. Miletich, whose career has spanned many fields of medicine, believes that we still don’t know enough about human disease biology. Fortunately, that is rapidly changing.
He shares more about how technology is transforming medicine for the better, leading to less bias and more knowledge about the complexity of human biology.
About Recursion:
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale - up to millions of wet lab experiments weekly - and massive computational scale - owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine.
Visit www.recursion.com/ to learn more.
#biology #chemistry #data #datascience #techbio #drugdiscovery #biotech #biotechnology #healthcare #health #medicine #innovation #ai #artificialintelligence #machinelearning #ml